Vimarsana
Biggest News Aggregation in the World

Page 4 - Emmac Life Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Emmac Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Emmac Life Sciences Today - Breaking & Trending Today

Marijuana is going global at a rapid pace - Vimarsana News

Marijuana is going global at a rapid pace

MONEYWEB app instead? Developments show that global receptiveness to marijuana is accelerating. By Tiffany Kary, Bloomberg 15 Mar 2021  07:45  Seemingly overnight, the cannabis industry has gone global. That can be seen in the deal just announced by Curaleaf Holdings Inc., the largest US cannabis company, that aims to turn Europe into a launchpad for international growth. Or take a look at British American Tobacco Plc’s new stake in a Canadian marijuana company, Organigram Holdings Inc. And then there’s the bill passed last week in Mexico that could make recreational marijuana ...

Curaleaf To Expand To Europe With $286 Million Acquisition - Vimarsana News

Curaleaf To Expand To Europe With $286 Million Acquisition

Cannabis Curaleaf in $286 Million deal to expand in Europe. Curaleaf, the largest cannabis company in the U.S., is on its way to become the largest of its kind in the world after announcing a $286 million deal to acquire European marijuana company Emmac Life Sciences. Boris Jordan, the billionaire executive chairman of Curaleaf, said during the company’s earning’s call on Tuesday that the acquisition is a “transformational launching point” and will turn the company into a dominant force in the global cannabis industry. Jordan, who owns a $2.5 billion stake in the company, said Europe...

Curaleaf CEO Touts Potential of European Cannabis Market on Back of $286M Acquisition - Vimarsana News

Curaleaf CEO Touts Potential of European Cannabis Market on Back of $286M Acquisition

Mar 12, 2021 09:10 pm By Chloe Aiello Share with U.S. cannabis company Curaleaf agreed to acquire London-based Emmac Life Sciences in a $286 million deal that represents the company’s first step into the burgeoning European cannabis market. “We think, although the market is just emerging, it's the addressable opportunity in Europe could actually be bigger than the addressable opportunity in the U.S., and this gives us an unparalleled platform to be able to build on,” Curaleaf CEO Joe Bayern told Cheddar. The cash and stock transaction is expected to close early in the second quarter of ...

Investegate |EMMAC Life Sciences Announcements | EMMAC Life Sciences: EMMAC to be acquired by Curaleaf - Vimarsana News

Investegate |EMMAC Life Sciences Announcements | EMMAC Life Sciences: EMMAC to be acquired by Curaleaf

  Curaleaf to Enter European Cannabis Market with Acquisition of EMMAC Life Sciences Limited - Europe's Leading Independent Cannabis Company EMMAC Brings the Largest Vertically Integrated Independent Cannabis Company in Europe with a Presence in Key European Medical Cannabis Markets, Including the United Kingdom, Germany, Italy, Spain, and Portugal With the European Population of Nearly 748 Million 1, the Potential Addressable Market is More than Twice the Size of U.S. Market     10 March, London. EMMAC Life Sciences Group, Europe's large...

Curaleaf Enters Europe Cannabis Market in $285 Million Deal - Vimarsana News

Curaleaf Enters Europe Cannabis Market in $285 Million Deal

Curaleaf Holdings Inc. agreed to buy Emmac Life Sciences Ltd. for about $285 million, giving the company entry into Europe’s rapidly growing cannabis market.

Source: msn.com